Nebraska was scheduled today to carry out America's first execution employing the opioid fentanyl as part of a four-drug combination that has never before been used.
The powerful synthetic painkiller -- a key cause of death in America's opioid and heroin abuse epidemic -- was to be the second injection administered to Carey Dean Moore, sentenced to death for two 1979 murders.
Moore is not contesting his execution, the Midwestern state's first in 21 years. But a last-minute legal challenge filed on his behalf could still cause a delay.
Underscoring the difficulty states across the country have had in obtaining previously employed execution drugs, three of the four intravenous medications Nebraska is scheduled to use have never before been used for lethal injections.
It is a pivotal test for the state, which last performed an execution in 1997 with the electric chair.
The American Civil Liberties Union yesterday asked the state's highest court to delay Moore's execution, according to the Omaha World-Herald newspaper.
The civil rights group claimed Moore's death sentence had been automatically commuted to a life sentence in 2015, when the Nebraska state legislature abolished the death penalty, the newspaper reported.
Nebraska voters reinstated capital punishment by referendum in the November 2016 election.
Moore has been on death row for 38 years and has said he does not want further delays.
While in his early 20s he was sentenced to death in 1980 for the killings of two Omaha taxi drivers five days apart.
Moore admitted to shooting to death the first driver during a robbery with his brother.
He publicly wrote in 2007 that the second killing occurred at the end of a cab ride, because "I had to foolishly prove to myself that I could take a man's life all by myself."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
